XIDX
SRSN
Market cap22mUSD
Nov 12, Last price
66.00IDR
Name
Indo Acidatama Tbk PT
Chart & performance
P/E
5.14
P/S
0.32
EPS
12.85
Div yield, %
1.52%
Shrs. gr., 5y
—
Rev. gr., 5y
7.11%
Revenues
1.26t
+8.89%
Net income
77.35b
+243.76%
CFO
255.84b
P
Dividend
Jun 02, 20261.1 IDR/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
PT Indo Acidatama Tbk specializes in the production and distribution of basic and agrochemicals, primarily serving the Indonesian market. Its comprehensive product portfolio encompasses ethanol, acetic acid, and ethyl acetate. Additionally, the company markets organic and bio-fertilizers under well-known brand names such as POMI, RANDEX, ALFINASE, and BEKA. Beyond its domestic operations, the firm also engages in export activities. Established in 1982, PT Indo Acidatama Tbk underwent a name change in May 2006, transitioning from its former identity as PT Sarasa Nugraha Tbk. Its operations are headquartered in West Jakarta, Indonesia.
Key people
Biantoro Setijo
President Commissioner · since 2017
Budhi Moeljono
President Director · since 2005
Budhi Santoso
Vice President Commissioner · since 2013
Sharad Ugrankar
Finance and Administration Director, Independent Director · since 2014
Mulyadi Utomo Budhi Moeljono
Vice President Director · since 2005
Nurdjono Kusumohadi
Plant Director · since 2005
Wong Lukas Yoyok Nurcahya
Administration Director · since 2021
Shelumiel Setijo
Business Development Director · since 2021
Benny Herman
Corporate Secretary · since 2001
Budhi Hartono
Commissioner · since 2003
Wymbo Widjaksono
Commissioner · since 2014
Stephanus Junianto
Independent Commissioner · since 2001
F. S. Bahari Nusantara
Independent Commissioner · since 2019
Valuation
Title IDR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||